Atlas Trials

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

Clinical trial NCT05053867 · RECRUITING

Trial details

NCT number
NCT05053867
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary HemorrhageCancer
Start date
2022-10-14
Primary completion
2027-07-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.